UNSPSC 51391605: Milrinone
Commodity
Code facts
- Part of
-
-
51000000
-
51390000
- 51391600
-
51390000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51391605
| NIGP code |
|---|
| 26912 Autonomic Drugs |
Definition
This classification denotes a phosphodiesterase inhibitor with the molecular formula C12H9N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JU9YAX04C7, chemically known as 1,6-dihydro-2-methyl-6-oxo-(3,4-bipyridine)-5-carbonitrile but generally known as milrinone, which bears US NIH Compound Identifier 4197. European Medicines Agency schedules Milrinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08968MIG.
Read the full definition
The term MILRINONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules milrinone in its Anatomical Therapeutic Chemical (ATC) Classification. MILRINONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule milrinone under HS 29337900 and SITC 51561. As of Q4 2014, MILRINONE remains the US FDA Preferred Term for this commodity. Milrinone bears US NLM identifiers UMLS ID C0128513 and NCI Concept Code C61848.
SMILES: O=C1[NH]C(C(C2CCNCC2)CC1C#N)C.
About UNSPSC 51391605
UNSPSC 51391605 Milrinone is a Commodity code that tracks pharmaceutical products—specifically injectable cardiac medications and related drug products—procured by state and local health agencies. Recent state and local solicitations under this code show governments acquiring naloxone (an opioid antagonist) and safe drug deactivation systems for community health programs, as well as pharmaceutical procurement through direct-to-manufacturer channels and pharmacy benefit programs. Issuing bodies include county health departments and state health and human services commissions. The work spans product procurement (unit purchases of specific medications and related supplies with quarterly or regular delivery cycles) and strategic pharmacy contracting (arrangement of direct vendor relationships to fulfill prescription and pharmaceutical supply requirements outside traditional pharmacy benefit manager channels).
Activity is concentrated in Florida and Texas, with Seminole County, Florida issuing a competitive IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (IFB 60459723LAS, due July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building in Sanford) and the Texas Health and Human Services Commission posting an RFI (HHS0017013, posted April 3, 2026) to gather vendor capabilities for implementing direct-to-manufacturer prescription programs for state pharmacy benefits. The Texas RFI represents exploratory procurement activity; the Seminole County IFB is a traditional competitive bid with a two-year initial term and one-year renewal option, fixed-fee pricing, and standard compliance requirements including E-Verify and workers' compensation insurance.
Quick answers
What is UNSPSC 51391605?
UNSPSC 51391605 is Milrinone, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51391605?
UNSPSC 51391605 maps to 1 NIGP code, 26912 Autonomic Drugs.
On GovTribe
See everything under UNSPSC 51391605
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code